Carine Kare Med Pro Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.35 Cr
- Revenue Growth 108.23%
- Profit Growth 9.23%
- Ebitda 162.50%
- Net Worth 32.05%
- Total Assets 214.05%
About Carine Kare Med Pro
Carine Kare Med Pro Private Limited (CKMPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 April 2012 and has a history of 12 years and ten months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.35 Cr.
Sai Vaikunth and Karuna Vaikunth serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85191TG2012PTC080190
- Company No.
080190
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Carine Kare Med Pro?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sai Vaikunth  | Director | 10-Apr-2012 | Current |
| Karuna Vaikunth | Director | 19-Nov-2012 | Current |
Financial Performance of Carine Kare Med Pro.
Carine Kare Med Pro Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 108.23% increase. The company also saw a slight improvement in profitability, with a 9.23% increase in profit. The company's net worth Soared by an impressive increase of 32.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Carine Kare Med Pro?
Unlock access to Carine Kare Med Pro's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹33.54 M
₹0
Charges Breakdown by Lending Institutions
- Others : 3.05 Cr
- Canara Bank : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2024 | Others | ₹1.60 Cr | Open |
| 21 Feb 2024 | Others | ₹1.45 Cr | Open |
| 10 Nov 2012 | Canara Bank | ₹3.00 M | Open |
How Many Employees Work at Carine Kare Med Pro?
Unlock and access historical data on people associated with Carine Kare Med Pro, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Carine Kare Med Pro, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Carine Kare Med Pro's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
